Euronext

Macquarie threatens LSE pullout

Macquarie Bank has confirmed it will not increase its current offer of 580p for shares in the London Stock Exchange (LSE) and has threatened to pull out of the running once that bid expires at the end of the month, according to a company statement.

Euronext goes live on single feed

Pan-European exchange Euronext is shutting down LMF 2, its derivatives data feed for the Brussels, Lisbon, London and Paris markets, after completing the consolidation of all of its feeds onto one platform.

UBS executes Bloomberg futures trades

UBS Investment Bank has become the exclusive executing broker for Bloomberg's Tradebook alternative trading system on the Chicago Board of Trade, Chicago Mercantile Exchange, Eurex and Euronext.liffe futures exchanges, reports Risknews’ sister…

LCH wins LSE clearing contract

The London Stock Exchange (LSE) has signed a new clearing services agreement with the London Clearing House (LCH), bringing to an end a period of intense competition with Eurex for the contract.

Euronext.liffe struggles with regulatory harmony

Regulation from continental Europe has acted as a "straightjacket" around Euronext.liffe’s efforts to bring all its derivatives products together on a single electronic trading platform, according to Nick Weinreb, head of group regulation at Euronext…

CBOT to use Liffe Connect

The Chicago Board of Trade (CBOT) has entered a licensing agreement to use Liffe Connect, the derivatives trading system used by pan-European exchange Euronext.Liffe, replacing the existing a/c/e platform currently being licensed from Eurex. The move…

Euronext pays CME $7.5m to settle Wagner patent dispute

Pan-European exchange Euronext will pay the Chicago Mercantile Exchange (CME) $7.5 million related to settlement of an indemnification dispute. The dispute revolves around the CME’s $15 million deal in August last year with electronic brokerage eSpeed…

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here